The enantioselective total synthesis of the antitumor macrolide natural product rhizoxin D

Tetrahedron Letters

Volumn 40, Issue 22, 1999, Pages 4145-4148

  Lafontaine, Jennifer A ^a   Provencal, David P ^a   Gardelli, Cristina ^a   Leahy, James W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MetaXen   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKENE; ANTINEOPLASTIC AGENT; MACROLIDE; NATURAL PRODUCT; RHIZOXIN; RHIZOXIN D; UNCLASSIFIED DRUG;

ARTICLE; CYCLIZATION; DRUG SYNTHESIS; ENANTIOMER;

EID: 0033612278     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(99)00731-5     Document Type: Article

References (33)

1. (a) Iwasaki, S.; Kobayashi, H.; Furukawa, J.; Namikoshi, M.; Okuda, S. J. Antibiot. 1984, 37, 354.
2. (b) Iwasaki, S.; Namikoshi, M.; Kobayashi, H.; Furukawa, J.; Okuda, S.; Itai, A.; Kasuya, A.; Iitaka, Y.; Sato, Z. J. Antibiot. 1986, 39, 424.
3. See, for example, Onozawa, C.; Shimamura, M.; Iwasaki, S.; Oikawa, T. Jpn. J. Cancer Res. 1997, 88, 1125 and references cited. The palmitate ester of rhizoxin (RS-1541) has also been studied ( see, for example Kurihara, A.; Shibayama, Y.; Kasuya, A.; Ikeda, M.; Hisaoka, M. J. Drug Target. 1998, 5, 491).
4. See, for example, Onozawa, C.; Shimamura, M.; Iwasaki, S.; Oikawa, T. Jpn. J. Cancer Res. 1997, 88, 1125 and references cited. The palmitate ester of rhizoxin (RS-1541) has also been studied ( see, for example Kurihara, A.; Shibayama, Y.; Kasuya, A.; Ikeda, M.; Hisaoka, M. J. Drug Target. 1998, 5, 491).
5. McLeod, H. L.; Murray, L. S.; Wanders, J.; Setanoians, A.; Graham, M.A..; Pavlidis, N.; Heinrich, B.; Huinink, W.W.T.; Wagener, D.J.T.; Aamdal, S.; Verweij, J. British J. Cancer, 1996, 74, 1944 and references cited.
6. (a) Iwasaki, S.; Namikoshi, M.; Kobayashi, H.; Furukawa, J.; Okuda, S. Chem. Pharm. Bull. 1986, 34, 1387.
7. (b) Kiyoto, S.; Kawai, Y.; Kawakita, T.; Kino, E.; Okuhara, M.; Uchida, I.; Tanaka, H.; Hashimoto, M.; Terano, H.; Kohsaka, M.; Aoki, H.; Imanaka, H. J. Antibiot. 1986, 39, 762.
8. (a) Kurihara, A.; Shibayama, Y.; Mizota, A.; Yasuno, A.; Ikeda, M.; Hisaoka, M. Biol. Pharm. Bull. 1996, 19, 252.
9. (b) Tokui, T.; Maeda, N.; Kuriowa, C.; Sasagawa, K.; Inoue, T.; Kawai, K.; Ikeda, T.; Komai, T. Pharm. Res. 1995, 12, 370.
10. (c) Takatori, T.; Koizumi, T.; Tokui, T.; Mitsuhashi, Y.; Shiraishi, A.; Tsuruo, T. Cancer Chemother. Pharmacol. 1995, 35, 283.
11. Kato, Y.; Ogawa, Y.; Imada, T.; Iwasaki, S.; Shimazaki, N.; Kobayaski, T.; Komai, T. J. Antibiot. 1991, 44, 66.
12. (a) Keck, G. E.; Savin, K. A.; Weglarz, M. A.; Cressman, E. N. K. Tetrahedron Lett. 1996, 37, 3291.
13. (b) White, J. D.; Nylund, C. S.; Green, N. J. Tetrahedron Lett. 1997, 38, 7329.
14. (c) White, J. D.; Holoboski, M. A.; Nylund, C. S.; Green, N. J. Tetrahedron Lett. 1997, 38, 7333.
15. (d) Burke, S. D.; Hong, J.; Mongin, A. P. Tetrahedron Lett. 1998, 39, 2239.
16. 10
17. (a) Kende, A. S.; Blass, B. E.; Henry, J. R. Tetrahedron Lett. 1995, 36, 4741.
18. (b) Williams, D. R.; Werner, K. M.; Feng, B. Tetrahedron Lett. 1997, 38, 6825.
19. For our initial efforts in this area, see: (a) Lafontaine, J. A.; Leahy, J. W. Tetrahedron Lett. 1995, 36, 6029. (b) Provencal, D. P.; Gardelli, C.; Lafontaine, J. A.; Leahy, J. W. Tetrahedron Lett. 1995, 36, 6033.
20. For our initial efforts in this area, see: (a) Lafontaine, J. A.; Leahy, J. W. Tetrahedron Lett. 1995, 36, 6029. (b) Provencal, D. P.; Gardelli, C.; Lafontaine, J. A.; Leahy, J. W. Tetrahedron Lett. 1995, 36, 6033.
21. Lafontaine, J. A., unpublished results.
22. 10 in the following manner: (equation presented)
23. Abiko, A.; Liu, J.; Masamune, S. J. Am. Chem. Soc. 1997, 119, 2586.
24. For an example of the use of barium hydroxide in Horner-Emmons olefinations, see: Paterson, I.; Yeung, K.; Smaill, J. B. Synlett 1993, 774.
25. Pilcher, A. S.; DeShong, P. J. Org. Chem. 1993, 58, 5130.
26. Evans, D. A.; Hoveyda, A. H. J. Am. Chem. Soc. 1990, 112, 6447.
27. 8Si: C, 66.07; H, 7.96; N, 3.95. Found: C, 65.74; H, 8.33; N, 3.67.
28. Baudin, J. B.; Hareau, G.; Julia, S. A.; Ruel, O. Tetrahedron Lett. 1991, 32, 1175.
29. 2: C, 56.73; H, 8.37; N, 2.28. Found: C, 56.80; H, 8.32; N, 2.13.
30. +): 1106.6842. Found: 1106.6849.
31. (a) Cooke, M. P.; Biciunas, K. P. Synthesis 1981, 283.
32. (b) Haseltine, J. N.; Cabal, M. P.; Mantlo, N. B.; Iwasawa, N.; Yamashita, D. S.; Coleman, R. S.; Danishefsky, S. J.; Schulte, G. K. J. Am. Chem. Soc. 1991, 113, 3850.
33. 3. Elemental analytical data were obtained from MHW Laboratories, Phoenix, AZ. High resolution mass spectra were obtained from the University of California College of Chemistry Microanalytical Facility.